Xiangzifan (Talk | contribs) |
Xiangzifan (Talk | contribs) |
||
Line 71: | Line 71: | ||
</div> | </div> | ||
</nav> | </nav> | ||
− | + | <div id="fh5co-blog"> | |
+ | <div class="container"> | ||
+ | <div class="row animate-box"> | ||
+ | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
+ | <h2>Market Analysis</h2> | ||
+ | <p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. | ||
+ | Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research. | ||
+ | From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market. | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
<div id="fh5co-started"> | <div id="fh5co-started"> |
Revision as of 17:19, 29 October 2017
Market Analysis
This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research. From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.
Hire Us!
Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.